Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-04-05 @ 8:54 AM
Study NCT ID:
NCT07432867
Status:
RECRUITING
Last Update Posted:
2026-03-04
First Post:
2026-01-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carrying a Corrected Globin Gene and a Silencing RNA.
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2032-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2033-02
Completion Date Type:
ESTIMATED
First Submit Date:
2026-01-02
First Submit QC Date:
None
Study First Post Date:
2026-02-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-02
Last Update Post Date:
2026-03-04
Last Update Post Date Type:
ACTUAL